Uox-Flox/Alb-Cre
Nomenclature
C57BL/6Smoc-Uoxem1(flox)Tg(Alb-Cre)Smoc
Cat. NO.
NM-XA-242357
Strain State
Repository Live
Model Description
Validation Data
Fig 1. Body Weight of Uox-Flox/Alb-Cre mouse.
Abbr. WT, wild type.
Fig 2. Uric acid (UA) levels of Uox-Flox/Alb-Cre mouse.
Fig 3. The results of blood biochemical indicators of Uox-Flox/Alb-Cre mouse.
Fig 4. Histological analysis of kidney revealed no obvious micro-morphological injury in 20-week old Uox-Flox/Alb-Cre male mice.
Fig 5. Effect of Allopurinol on Serum Uric Acid Levels. 6 week-old Uox-Flox/Alb-Cre male mice were Treated with Allopurinol. Compared to C57BL/6, serum uric acid levels of Uox-Flox/Alb-Cre male mice were significantly elevated. Treatment with allopurinol (100mg/kg) significantly reduced serum uric acid levels in Uox-Flox/Alb-Cre male mice (n=10). Values are expressed as mean ± SEM.
Fig 6. Body Weight Comparison. The body weight of Uox-Flox/Alb-Cre male mice was lower compared to C57BL/6 mice. Allopurinol treatment had no effect on body weight (n=10). Values are expressed as mean ± SEM.
Fig 7. Kidney Function Assessment. Kidney function in Uox-Flox/Alb-Cre male mice showed no significant difference compared to C57BL/6 mice (n=10). Values are expressed as mean ± SEM.
You may also like
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreSMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn more
